Xtant Medical Holdings, Inc.XTNTEarnings & Financial Report
NYSE
XTNT Q3 2025 Key Financial Metrics
Revenue
$33.3M
Gross Profit
$22.0M
Operating Profit
$2.5M
Net Profit
$1.3M
Gross Margin
66.1%
Operating Margin
7.6%
Net Margin
3.9%
YoY Growth
19.0%
EPS
$0.01
Financial Flow
Xtant Medical Holdings, Inc. Q3 2025 Financial Summary
Xtant Medical Holdings, Inc. reported revenue of $33.3M for Q3 2025, with a net profit of $1.3M (3.9% margin). Cost of goods sold was $11.3M, operating expenses totaled $19.5M.
Key Financial Metrics
| Total Revenue | $33.3M |
|---|---|
| Net Profit | $1.3M |
| Gross Margin | 66.1% |
| Operating Margin | 7.6% |
| Report Period | Q3 2025 |
Xtant Medical Holdings, Inc. Annual Revenue by Year
Xtant Medical Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $117.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $117.3M |
| 2023 | $91.3M |
| 2022 | $58.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.1M | $27.9M | $29.9M | $27.9M | $31.5M | $32.9M | $35.4M | $33.3M |
| YoY Growth | 84.1% | 55.3% | 48.0% | 11.7% | 12.1% | 18.0% | 18.3% | 19.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $92.6M | $93.9M | $95.6M | $98.9M | $93.8M | $95.8M | $103.5M | $106.3M |
| Liabilities | $41.3M | $46.3M | $50.6M | $53.2M | $50.9M | $52.0M | $55.0M | $55.9M |
| Equity | $51.3M | $47.7M | $45.0M | $45.7M | $43.0M | $43.9M | $48.5M | $50.4M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-915000 | $-5.8M | $-5.1M | $-1.7M | $665000 | $1.3M | $1.3M | $4.6M |